arrow_back Search

EFTA01939674

DOJ Epstein Files
folder Dataset 10 insert_drive_file EFTA01939674.pdf description PDF text_fields 252 words · 1.9k chars
open_in_new View original source

To: Jeffrey epstein aeevacation@gmail.com)fjeffrey epstein (jeevacation6gmail.com)J: jeevacationegmail.comUeevacation©gmail.comi From: Boris Nikolic Sent Wed 2/5/2014 8:26:02 PM Subject: FW: Bio Larry checked with all teams and I got approval for what I did — below. There is also part of my previous Harvard life that I cut down significantly. Finishing other parts as well. B From: Larry Cohen Sent: Wednesday, February 5, 2014 11:17 AM To: Boris Nikolic Subject: Bio Bill and Julie have approved this (below) Good? Most recently, Dr. Boris Nikolic served as Chief Advisor for Science and Technology to Bill Gates at bgC3 (the private office of Bill Gates) and at the Bill & Melinda Gates Foundation (BMGF). Boris is now focused full time on the DST healthcare fund. Nikolic led select for-profit and not-for-profit investment activities at these Gates-affiliated organizations. EFTA_R1_00397422 EFTA01939674 On the for-profit side, Nikolic led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus. On the not-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on program-related investments in global health, as well as in other program areas (agriculture, digital payments and US education). Boris focused on biotech investments specifically, and pioneered direct equity investments by a US foundation in companies with platform technologies applicable to global health. BMGF's biotech portfolio includes five biotech companies: Liquidia, Genocea, Visterra, Atreca and Anacor. At BMGF, Boris also led discovery program of novel diagnostics platform technologies, molecular diagnostics point-of-care applications, novel immunological detection systems, vaccination and surveillance technologies. EFTA_R1_00397423 EFTA01939675